The Forgotten Power of the TPP: Why Many Biopharma Projects Fail Without It
In the fast‐moving world of biopharma innovation, it’s easy to get excited by the science – the novel target, the breakthrough molecule, the cutting-edge modality. But amid that excitement, one strategic document often gets overlooked or relegated to a checkbox: the Target Product Profile (TPP). Too often, teams pour years of effort and resources into a promising molecule, only to realize late in the process that what they’ve built isn’t quite what the regulators, payers, or patients actually needed. That’s a missed opportunity, because when used right, a well-crafted TPP doesn’t just guide development. It connects science with strategy, aligning every function — from R&D and regulatory to commercial and manufacturing — around one clear vision of what success should look like. What Exactly Is a TPP? At its core, a Target Product Profile (TPP) is a living blueprint that defines the intended attributes of a future therapeutic product. It outlines key elements like indication, pat...